Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Alignment Healthcare (ALHC) Long-Term Debt Issuances (2024)

Alignment Healthcare's Long-Term Debt Issuances history spans 1 years, with the latest figure at $330.0 million for Q4 2024.

For Q4 2024, Long-Term Debt Issuances changed N/A year-over-year to $330.0 million; the TTM value through Dec 2025 reached $330.0 million, changed 0.0%, while the annual FY2024 figure was $380.0 million, N/A changed from the prior year.
Long-Term Debt Issuances reached $330.0 million in Q4 2024 per ALHC's latest filing, up from $50.0 million in the prior quarter.
In the past five years, Long-Term Debt Issuances ranged from a high of $330.0 million in Q4 2024 to a low of $50.0 million in Q2 2024.